CAPPED BONUSZERTIFIKAT - MERCK & CO. Stock

Certificat

DE000PC75896

Real-time Boerse Frankfurt Warrants 10:20:50 2024-05-29 am EDT
115.7 EUR -0.12% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month-2.74%
1 month-3.37%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-29 115.7 -0.12%
24-05-28 115.9 -2.12%
24-05-27 118.4 +0.09%
24-05-24 118.3 -1.42%
24-05-23 120 +0.09%

Real-time Boerse Frankfurt Warrants

Last update May 29, 2024 at 10:20 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC7589
ISINDE000PC75896
Date issued 2024-04-11
Strike 150 $
Maturity 2025-06-20 (387 Days)
Parity 1 : 1
Emission price 112.9
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 120.4
Lowest since issue 114.8
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.1 USD
Average target price
141.9 USD
Spread / Average Target
+12.52%
Consensus